Vol 3, No 3 (2004): Polish Palliative Medicine
Artykuły poglądowe
Published online: 2004-04-27
The involvement of cardiovascular system in patients with lung cancer
Piotr Sobański
Advances in Palliative Medicine 2004;3(3):265-280.
Vol 3, No 3 (2004): Polish Palliative Medicine
Artykuły poglądowe
Published online: 2004-04-27
Abstract
Patients with malignant tumours of the lungs often present with symptoms and signs of cardiovascular
pathology as well as with abnormal results of the diagnostic tests. In such situations oncologists are faced
with difficult therapeutic decisions. These may concern qualification or disqualification for a particular
modality of oncological treatment. Scrupulous assessment enables radical anti-tumoral treatment to be
started. This also applies to patients with cardiovascular risk factors, provided, however, that the risk is
relatively low and there is a real chance of survival of the period of active cardiological treatment. In patients
with advanced disease, may become difficult. In such cases of advanced malignancy interventions should be
limited to correction of the abnormalities, disapperance of which may improve the patient’s survival or
quality of live. Sometimes it becomes difficult to find out which cardiovascular pathologies accompanying
the malignancy are clinically significant. This article describes basic symptoms and signs, diagnostic and
treatment modalities of the cardiovascular diseases caused by malignancy and also catalogues the cardiovascular
side-effects of oncological treatment.
Abstract
Patients with malignant tumours of the lungs often present with symptoms and signs of cardiovascular
pathology as well as with abnormal results of the diagnostic tests. In such situations oncologists are faced
with difficult therapeutic decisions. These may concern qualification or disqualification for a particular
modality of oncological treatment. Scrupulous assessment enables radical anti-tumoral treatment to be
started. This also applies to patients with cardiovascular risk factors, provided, however, that the risk is
relatively low and there is a real chance of survival of the period of active cardiological treatment. In patients
with advanced disease, may become difficult. In such cases of advanced malignancy interventions should be
limited to correction of the abnormalities, disapperance of which may improve the patient’s survival or
quality of live. Sometimes it becomes difficult to find out which cardiovascular pathologies accompanying
the malignancy are clinically significant. This article describes basic symptoms and signs, diagnostic and
treatment modalities of the cardiovascular diseases caused by malignancy and also catalogues the cardiovascular
side-effects of oncological treatment.
Keywords
lung cancer; cardiac metastases; pulmonary embolism; arrhythmias; pericarditis; tamponade
Keywords
lung cancer
cardiac metastases
pulmonary embolism
arrhythmias
pericarditis
tamponade